Carregant...

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

BACKGROUND: Despite current therapies, diffuse cutaneous systemic sclerosis (scleroderma) often has a devastating outcome. We compared myeloablative CD34+ selected autologous hematopoietic stem-cell transplantation with immunosuppression by means of 12 monthly infusions of cyclophosphamide in patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:N Engl J Med
Autors principals: Sullivan, K.M., Goldmuntz, E.A., Keyes-Elstein, L., McSweeney, P.A., Pinckney, A., Welch, B., Mayes, M.D., Nash, R.A., Crofford, L.J., Eggleston, B., Castina, S., Griffith, L.M., Goldstein, J.S., Wallace, D., Craciunescu, O., Khanna, D., Folz, R.J., Goldin, J., St Clair, EW, Seibold, J.R., Phillips, K., Mineishi, S., Simms, R.W., Ballen, K., Wener, M.H., Georges, G.E., Heimfeld, S., Hosing, C., Forman, S., Kafaja, S., Silver, R.M., Griffing, L., Storek, J., LeClercq, S., Brasington, R., Csuka, M.E., Bredeson, C., Keever-Taylor, C., Domsic, R.T., Kahaleh, M.B., Medsger, T., Furst, D.E.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846574/
https://ncbi.nlm.nih.gov/pubmed/29298160
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!